Older Patients with Cancer-Related Breakthrough Pain Tolerate Sublingual Fentanyl Tablets
Sublingual fentanyl tablets were generally well tolerated in patients with cancer-related breakthrough pain aged 65 years and older in conjunction with around-the-clock opioid treatment, investigators reported during the American Pain Society’s 30th Annual Scientific Meeting.